BIO-Europe Spring 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

BIO-Europe Spring 2013


BIO-Europe Spring® 2013 — 7th International Partnering Conference
Where the global biotech industry comes to partner

Location:
Barcelona, Spain

Date:
March 11–13, 2013

Venue:
CCIB Convention Centre Barcelona

Venue address:
CCIB Convention Centre
Rambla Prim 1–17
08019 Barcelona
Spain

Venue website:
www.ccib.es

Event Website:
www.ebdgroup.com/bes

The seventh annual BIO-Europe Spring® conference is the premier springtime partnering conference for the biotechnology industry. For its 2013 edition, BIO-Europe Spring comes to Barcelona, Spain on March 11–13, 2013.

The conference annually attracts the international “who’s who” from biotech, pharma and finance for three days of high caliber networking. BIO-Europe Spring’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. Attend BIO-Europe Spring and take advantage of the opportunity for more partnering meetings in the three days of the conference than in the rest of the year.

Based on attendance at previous events, BIO-Europe Spring 2013 will bring together more than 2,200 executives from biotechnology, pharmaceutical and finance companies from around the world, who will engage in some 12,000 partnering meetings.

Partnering at BIO-Europe Spring is powered by partneringONE®, the leading conference solution for helping life science delegates meet efficiently and effectively. partneringONE has the unique ability to manage the complex interactions among thousands of executives from many different companies.

This sophisticated web-based partnering system enables delegates to screen potential partners, pre-arrange meetings and manage the entire conference partnering process.

Delegates can log in and connect with the conference community, anytime, anywhere.

Producer:
EBD Group AG

Supported by:
Biotechnology Industry Organization (BIO)

Contacts:
In the USA
Christina Hundschell
2032 Corte del Nogal, Suite 120
Carlsbad, CA 92011, USA
T: +1 760 930 0500
F: +1 760 030 0520
chundschell@ebdgroup.com

In Europe
Manuela Hildebrand
Isartorplatz 4
80331 Munich
Germany
T: +49 89 23 88 756 0
F: +49 89 23 88 756 55
mhildebrand@ebdgroup.com

Intended for:
Executives from:

  • Established and emerging biotech and medtech companies
  • Pharmaceutical companies
  • Institutional financial firms
  • Private investors including venture capital and private equity firms
  • Other industry related service companies

Speakers:
Please see website

Cost:
Please see website: http://www.ebdgroup.com/bes/registration

Program:
Please see website: http://www.ebdgroup.com/bes/program/index.php

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here